Humacyte Inc. Warrant (HUMAW)
Stock · NASDAQ · Health Care
$0.0009as of 8/25/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
Resistance level
$0.007719
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Humacyte Inc. Warrant Competitors
Chosen by industry and closest market cap.
- HUMAWHumacyte Inc. Warrant$0.0009▼ 78.05%Market cap $1.82MP/E —
- SCNIScinai Immunotherapeutics Ltd. American Depositary Shares$2.53▼ 5.60%Market cap $1.37MP/E 0.14$2.15$16.8
- VIVSVivoSim Labs Inc. Common Stock$0.29▲ 0.00%Market cap $4.03MP/E —$0.2625$5.3
- PHGEBiomX Inc. COmmon Stock$0.138▲ 4.55%Market cap $4.62MP/E —$0.1192$12.29
- BCABBioAtla Inc. Common Stock$1.79▼ 42.99%Market cap $5.41MP/E —$2.81$71.5
- AIMAIM ImmunoTech Inc. Common Stock$0.2558▲ 2.32%Market cap $7.32MP/E —$0.1901$2.89
- BCDABioCardia Inc. Common Stock$1.16▼ 0.85%Market cap $9.45MP/E —$0.75$2.29
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| HUMAW Humacyte Inc. Warrant | $1.82M | — | $0.0009 | ▼ 78.05% | |
| SCNI Scinai Immunotherapeutics Ltd. American Depositary Shares | $1.37M | 0.14 | $2.53 | ▼ 5.60% | $2.15$16.8 |
| VIVS VivoSim Labs Inc. Common Stock | $4.03M | — | $0.29 | ▲ 0.00% | $0.2625$5.3 |
| PHGE BiomX Inc. COmmon Stock | $4.62M | — | $0.138 | ▲ 4.55% | $0.1192$12.29 |
| BCAB BioAtla Inc. Common Stock | $5.41M | — | $1.79 | ▼ 42.99% | $2.81$71.5 |
| AIM AIM ImmunoTech Inc. Common Stock | $7.32M | — | $0.2558 | ▲ 2.32% | $0.1901$2.89 |
| BCDA BioCardia Inc. Common Stock | $9.45M | — | $1.16 | ▼ 0.85% | $0.75$2.29 |
P/E shows — for peers not currently carrying a live signal of their own.
Institutional Ownership
March 31, 2026
- Total shares held
- 567.1K
- Total value held
- $51.8K
- Institutional holders
- 8
Top holders this quarter
- Unknown259.6K
- Unknown62.5K
- Unknown50.0K
- Unknown50.0K
- Unknown44.5K
- Unknown42.1K
- Unknown38.0K
- Unknown20.4K
See the full, filterable feed with live charts on the MarketWall dashboard.